Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcranial photobiomodulation therapy with 808 nm and 1064 nm can affect different behavior parameters in dogs.

Lasers in medical science·2026
Same author

Assessment of environmental radioactivity in the City of Melilla.

Scientific reports·2026
Same author

Initial psychometric evaluation of the European Portuguese version of the Lincoln Canine Adaptability Resilience Scale.

PloS one·2025
Same author

Indoor radon risk mapping of the Canary Islands using a methodology for volcanic islands combining geological information and terrestrial gamma radiation data.

The Science of the total environment·2024
Same author

Multiparametric analysis for the determination of radon potential areas in buildings on different soils of volcanic origin.

The Science of the total environment·2023
Same author

Methodology for determination of radon prone areas combining the definition of a representative building enclosure and measurements of terrestrial gamma radiation.

The Science of the total environment·2021

Related Experiment Video

Updated: Jun 26, 2026

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model
08:16

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model

Published on: February 11, 2019

A target control Infusion method for neuromuscular blockade based on hybrid parameter estimation.

H Alonso1, J M Lemos, T Mendonça

  • 1FCUP, R. do Campo Alegre 687, 4169-007 Porto, Portugal. hugo.alonso@fc.up.pt

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
|January 24, 2009
PubMed
Summary

This study introduces a novel target control infusion (TCI) method for precise neuromuscular blockade (NMB) control during general anesthesia. The approach enhances patient safety by accurately estimating drug effects using pharmacokinetic/pharmacodynamic (PK/PD) models.

More Related Videos

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
03:26

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

Published on: March 8, 2024

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve
06:36

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve

Published on: September 26, 2018

Related Experiment Videos

Last Updated: Jun 26, 2026

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model
08:16

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model

Published on: February 11, 2019

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
03:26

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

Published on: March 8, 2024

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve
06:36

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve

Published on: September 26, 2018

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Biomedical Engineering

Background:

  • Neuromuscular blockade (NMB) is crucial for general anesthesia, but precise control remains challenging.
  • Existing methods may lack accuracy in real-time drug effect estimation.
  • Pharmacokinetic/pharmacodynamic (PK/PD) models are essential for understanding drug behavior in the body.

Purpose of the Study:

  • To develop and evaluate a new target control infusion (TCI) method for NMB level control.
  • To improve the accuracy of NMB level management during general anesthesia.
  • To integrate PK/PD modeling with advanced parameter estimation techniques.

Main Methods:

  • A novel TCI method combining PK/PD model inversion with a hybrid parameter estimation technique.
  • Utilizing on-line data from the initial bolus response for real-time parameter estimation.
  • Simulations conducted on a diverse bank of 100 patient models.

Main Results:

  • The proposed TCI method demonstrated effective control of NMB levels.
  • Accurate estimation of PK/PD model parameters was achieved using on-line data.
  • The method showed robust performance across a range of simulated patient models.

Conclusions:

  • The developed TCI method offers a promising approach for precise NMB level control in general anesthesia.
  • This technique can be adapted for various neuromuscular blocking agents with available PK/PD models.
  • The findings support the potential for enhanced patient safety and optimized anesthetic management.